Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Cordlife Group ( (SG:P8A) ) is now available.
Cordlife Group Limited has resumed its operations in Singapore after receiving the necessary licenses from the Ministry of Health, marking a positive step towards rebuilding client confidence and operational momentum. The company is addressing customer concerns related to high-risk storage tanks by offering refunds and waivers, while also strengthening its collaborations with the medical community to ensure transparency and improved procedures.
More about Cordlife Group
Cordlife Group Limited is a company based in Singapore that operates in the healthcare industry, specializing in cord blood and human tissue banking services. The company focuses on safeguarding future health outcomes through its services and actively engages with the medical community to strengthen its ecosystem.
Average Trading Volume: 131,017
Technical Sentiment Signal: Hold
Current Market Cap: S$68.93M
See more data about P8A stock on TipRanks’ Stock Analysis page.